GGrantIndex
← Leaderboards

William Francis Benedict

University Of Texas Md Anderson Can Ctr

$3,785,293
Attributed
$5,454,687
Total exposure
11
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $812.8K · FY200516
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16

Funding mix

By agency

NIH$5,454,687 · 11

By mechanism

P50$3,634,695 · 9
R01$1,819,992 · 2

Top collaborators

Most similar at University Of Texas Md Anderson Can Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasm Of Urinary Bladder

Research focus

Malignant Neoplasm Of Urinary BladderResearch PersonnelFundingProgramsUrogenital CancerCostBaseCareer DevelopmentTranslational ResearchFutureCommunicationInterestScientistUniversity Of Texas M D Anderson Cancer CenterAnticancer ResearchClinical ManagementIncidenceMalignant NeoplasmsCancer Research ProjectResourcesSeedsProtocols DocumentationRecruitment ActivityPlay

Grant awards (27)

Administrative Core$218,137
P50 · FY2016 · CA
Developmental Research Program$161,370
P50 · FY2016 · CA
Career Development Program$160,861
P50 · FY2016 · CA · contact PI
Administrative Core$219,381
P50 · FY2015 · CA
Developmental Research Program$162,009
P50 · FY2015 · CA
Career Development Program$161,496
P50 · FY2015 · CA · contact PI
Administrative Core$216,885
P50 · FY2014 · CA
Developmental Research Program$163,044
P50 · FY2014 · CA
Career Development Program$162,561
P50 · FY2014 · CA · contact PI
Administrative Core$215,641
P50 · FY2013 · CA
Career Development Program$163,429
P50 · FY2013 · CA · contact PI
Developmental Research Program$163,429
P50 · FY2013 · CA
Intravesical Gene Therapy for BCG Refractory Bladder Cancer$203,200
P50 · FY2012 · CA · contact PI
Administrative Core$203,200
P50 · FY2012 · CA
Developmental Research Program$203,199
P50 · FY2012 · CA
Career Development Program$203,199
P50 · FY2012 · CA · contact PI
Improving Gene Therapy for Superficial Bladder Cancer$232,753
P50 · FY2010 · CA · contact PI
Improving Gene Therapy for Superficial Bladder Cancer$236,948
P50 · FY2009 · CA · contact PI
Improving Gene Therapy for Superficial Bladder Cancer$183,953
P50 · FY2008 · CA · contact PI
RB4 Intravesical Gene Therapy: Mechanisms of Cell Death$318,565
R01 · FY2007 · CA · contact PI
RB4 Intravesical Gene Therapy: Mechanisms of Cell Death$328,079
R01 · FY2006 · CA · contact PI
RB4 Intravesical Gene Therapy: Mechanisms of Cell Death$335,975
R01 · FY2005 · CA
RB4 Intravesical Gene Therapy: Mechanisms of Cell Death$335,975
R01 · FY2004 · CA
RB4 Intravesical Gene Therapy: Mechanisms of Cell Death$335,975
R01 · FY2003 · CA
IMPROVING GENE THERAPY FOR SUPERFICIAL BLADDER CANCER$0
P50 · FY2002 · CA
IMPROVING GENE THERAPY FOR SUPERFICIAL BLADDER CANCER$0
P50 · FY2001 · CA
BIOCHEMICAL AND CYTOGENETIC MARKERS IN RETINOBLASTOMA$165,423
R01 · FY2000 · CA